Structure

Physi-Chem Properties

Molecular Weight:  270.09
Volume:  276.329
LogP:  3.752
LogD:  3.631
LogS:  -3.855
# Rotatable Bonds:  2
TPSA:  62.83
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.743
Synthetic Accessibility Score:  2.142
Fsp3:  0.125
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.808
MDCK Permeability:  1.5106834325706586e-05
Pgp-inhibitor:  0.005
Pgp-substrate:  0.972
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.107

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.016
Plasma Protein Binding (PPB):  98.36360931396484%
Volume Distribution (VD):  0.572
Pgp-substrate:  2.1918063163757324%

ADMET: Metabolism

CYP1A2-inhibitor:  0.969
CYP1A2-substrate:  0.921
CYP2C19-inhibitor:  0.828
CYP2C19-substrate:  0.068
CYP2C9-inhibitor:  0.653
CYP2C9-substrate:  0.922
CYP2D6-inhibitor:  0.774
CYP2D6-substrate:  0.913
CYP3A4-inhibitor:  0.804
CYP3A4-substrate:  0.262

ADMET: Excretion

Clearance (CL):  10.991
Half-life (T1/2):  0.824

ADMET: Toxicity

hERG Blockers:  0.014
Human Hepatotoxicity (H-HT):  0.172
Drug-inuced Liver Injury (DILI):  0.962
AMES Toxicity:  0.432
Rat Oral Acute Toxicity:  0.144
Maximum Recommended Daily Dose:  0.833
Skin Sensitization:  0.663
Carcinogencity:  0.484
Eye Corrosion:  0.015
Eye Irritation:  0.934
Respiratory Toxicity:  0.324

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC188486

Natural Product ID:  NPC188486
Common Name*:   Pterolinus B
IUPAC Name:   2-(4-hydroxyphenyl)-6-methoxy-3-methyl-1-benzofuran-5-ol
Synonyms:   Pterolinus B
Standard InCHIKey:  CQFHUONRLJIEPG-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C16H14O4/c1-9-12-7-13(18)15(19-2)8-14(12)20-16(9)10-3-5-11(17)6-4-10/h3-8,17-18H,1-2H3
SMILES:  COc1cc2oc(c(c2cc1O)C)c1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1801599
PubChem CID:   53262811
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1087 Pterocarpus santalinus Species Fabaceae Eukaryota Heartwood India n.a. PMID[21488654]
NPO1087 Pterocarpus santalinus Species Fabaceae Eukaryota n.a. heartwood n.a. PMID[21488654]
NPO1087 Pterocarpus santalinus Species Fabaceae Eukaryota heartwood n.a. n.a. PMID[21784631]
NPO1087 Pterocarpus santalinus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO1087 Pterocarpus santalinus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO1087 Pterocarpus santalinus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO1087 Pterocarpus santalinus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens IC50 = 2.34 ug.mL-1 PMID[506183]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 1.74 ug.mL-1 PMID[506183]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 0.19 ug.mL-1 PMID[506183]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 47.83 ug.mL-1 PMID[506183]
NPT2 Others Unspecified IC50 = 0.19 ug.mL-1 PMID[506183]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC188486 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9935 High Similarity NPC84515
0.9935 High Similarity NPC312056
0.9868 High Similarity NPC16935
0.9868 High Similarity NPC196879
0.9742 High Similarity NPC133065
0.9742 High Similarity NPC39305
0.9742 High Similarity NPC1755
0.9742 High Similarity NPC1706
0.9742 High Similarity NPC59295
0.9742 High Similarity NPC263092
0.9737 High Similarity NPC45131
0.9682 High Similarity NPC247973
0.9679 High Similarity NPC39306
0.9679 High Similarity NPC45449
0.9679 High Similarity NPC36320
0.9677 High Similarity NPC238995
0.9551 High Similarity NPC272722
0.9539 High Similarity NPC125300
0.95 High Similarity NPC230619
0.95 High Similarity NPC54098
0.95 High Similarity NPC174700
0.9494 High Similarity NPC277480
0.9481 High Similarity NPC472461
0.9441 High Similarity NPC473834
0.9441 High Similarity NPC216842
0.9441 High Similarity NPC82217
0.9441 High Similarity NPC476640
0.9441 High Similarity NPC310794
0.9434 High Similarity NPC50394
0.9434 High Similarity NPC470704
0.943 High Similarity NPC291110
0.943 High Similarity NPC37183
0.9383 High Similarity NPC287243
0.9375 High Similarity NPC247136
0.9359 High Similarity NPC195832
0.9351 High Similarity NPC88645
0.9351 High Similarity NPC206238
0.9351 High Similarity NPC292214
0.9351 High Similarity NPC167091
0.9351 High Similarity NPC271779
0.9325 High Similarity NPC8127
0.9325 High Similarity NPC49667
0.9317 High Similarity NPC476641
0.9317 High Similarity NPC131866
0.9313 High Similarity NPC86477
0.9308 High Similarity NPC29411
0.9295 High Similarity NPC99597
0.9295 High Similarity NPC210084
0.929 High Similarity NPC20830
0.929 High Similarity NPC256612
0.929 High Similarity NPC2928
0.9286 High Similarity NPC293183
0.9286 High Similarity NPC57030
0.9286 High Similarity NPC187498
0.9286 High Similarity NPC241498
0.9286 High Similarity NPC131624
0.9286 High Similarity NPC198826
0.9286 High Similarity NPC161277
0.9286 High Similarity NPC275722
0.9286 High Similarity NPC39007
0.9286 High Similarity NPC212678
0.9286 High Similarity NPC83508
0.9286 High Similarity NPC301323
0.9286 High Similarity NPC25270
0.9286 High Similarity NPC120163
0.9286 High Similarity NPC199100
0.9286 High Similarity NPC275836
0.9286 High Similarity NPC100887
0.9286 High Similarity NPC120537
0.9286 High Similarity NPC256283
0.9286 High Similarity NPC71334
0.9286 High Similarity NPC156222
0.9286 High Similarity NPC180234
0.9286 High Similarity NPC239128
0.9286 High Similarity NPC222830
0.9286 High Similarity NPC188203
0.9286 High Similarity NPC101996
0.9286 High Similarity NPC162313
0.9276 High Similarity NPC287395
0.9276 High Similarity NPC183655
0.9245 High Similarity NPC110257
0.9231 High Similarity NPC472916
0.9231 High Similarity NPC235165
0.9231 High Similarity NPC255106
0.9226 High Similarity NPC183878
0.9226 High Similarity NPC160951
0.9226 High Similarity NPC255350
0.9226 High Similarity NPC69394
0.9226 High Similarity NPC176775
0.9226 High Similarity NPC47781
0.9226 High Similarity NPC145379
0.9226 High Similarity NPC22519
0.9226 High Similarity NPC274327
0.9226 High Similarity NPC231018
0.9221 High Similarity NPC171010
0.9221 High Similarity NPC251110
0.9221 High Similarity NPC115324
0.9221 High Similarity NPC117579
0.9221 High Similarity NPC149614
0.9216 High Similarity NPC102003
0.9216 High Similarity NPC92722
0.9211 High Similarity NPC17816
0.9202 High Similarity NPC65885
0.9202 High Similarity NPC261471
0.9182 High Similarity NPC81679
0.9177 High Similarity NPC476980
0.9172 High Similarity NPC241904
0.9172 High Similarity NPC472914
0.9172 High Similarity NPC129684
0.9172 High Similarity NPC472911
0.9172 High Similarity NPC48208
0.9172 High Similarity NPC222814
0.9172 High Similarity NPC162869
0.9172 High Similarity NPC245758
0.9172 High Similarity NPC475267
0.9172 High Similarity NPC262286
0.9172 High Similarity NPC36852
0.9172 High Similarity NPC472910
0.9172 High Similarity NPC78225
0.9172 High Similarity NPC474208
0.9172 High Similarity NPC156057
0.9172 High Similarity NPC469584
0.9172 High Similarity NPC299520
0.9172 High Similarity NPC181960
0.9172 High Similarity NPC472913
0.9172 High Similarity NPC96167
0.9172 High Similarity NPC300727
0.9172 High Similarity NPC474836
0.9167 High Similarity NPC208197
0.9167 High Similarity NPC163780
0.9167 High Similarity NPC183597
0.9167 High Similarity NPC44079
0.9167 High Similarity NPC50715
0.9167 High Similarity NPC227325
0.9167 High Similarity NPC92659
0.9167 High Similarity NPC128863
0.9167 High Similarity NPC201136
0.9167 High Similarity NPC146165
0.9167 High Similarity NPC4455
0.9167 High Similarity NPC2476
0.9167 High Similarity NPC167815
0.9167 High Similarity NPC201451
0.9167 High Similarity NPC196439
0.9167 High Similarity NPC26227
0.9167 High Similarity NPC138360
0.9167 High Similarity NPC213622
0.9167 High Similarity NPC280339
0.9161 High Similarity NPC35763
0.9161 High Similarity NPC269451
0.9161 High Similarity NPC181209
0.9161 High Similarity NPC39732
0.9161 High Similarity NPC207624
0.9161 High Similarity NPC209487
0.9161 High Similarity NPC216769
0.9161 High Similarity NPC142540
0.9161 High Similarity NPC60972
0.9161 High Similarity NPC131266
0.9161 High Similarity NPC245382
0.9161 High Similarity NPC291802
0.9161 High Similarity NPC121522
0.9161 High Similarity NPC100263
0.9161 High Similarity NPC304954
0.9161 High Similarity NPC100971
0.9156 High Similarity NPC62042
0.9156 High Similarity NPC61620
0.9156 High Similarity NPC29231
0.9156 High Similarity NPC45873
0.9156 High Similarity NPC184136
0.9156 High Similarity NPC306821
0.9156 High Similarity NPC248102
0.9156 High Similarity NPC179183
0.9152 High Similarity NPC297807
0.9152 High Similarity NPC98546
0.915 High Similarity NPC131451
0.915 High Similarity NPC15329
0.9146 High Similarity NPC290304
0.9146 High Similarity NPC236327
0.9146 High Similarity NPC227906
0.9141 High Similarity NPC28589
0.9141 High Similarity NPC248593
0.9136 High Similarity NPC211309
0.9136 High Similarity NPC202470
0.9125 High Similarity NPC475985
0.9119 High Similarity NPC162668
0.9119 High Similarity NPC308992
0.9119 High Similarity NPC258331
0.9114 High Similarity NPC476242
0.9114 High Similarity NPC55738
0.9108 High Similarity NPC274730
0.9108 High Similarity NPC247017
0.9108 High Similarity NPC68093
0.9108 High Similarity NPC43243
0.9108 High Similarity NPC245546
0.9108 High Similarity NPC49824
0.9108 High Similarity NPC191146
0.9108 High Similarity NPC98661
0.9108 High Similarity NPC266960
0.9108 High Similarity NPC138243
0.9103 High Similarity NPC124714
0.9103 High Similarity NPC250822

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC188486 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9226 High Similarity NPD2801 Approved
0.9108 High Similarity NPD3882 Suspended
0.9038 High Similarity NPD1934 Approved
0.8766 High Similarity NPD1511 Approved
0.8742 High Similarity NPD2393 Clinical (unspecified phase)
0.8727 High Similarity NPD3818 Discontinued
0.8704 High Similarity NPD5494 Approved
0.8659 High Similarity NPD3926 Phase 2
0.8654 High Similarity NPD1512 Approved
0.865 High Similarity NPD1247 Approved
0.8606 High Similarity NPD6168 Clinical (unspecified phase)
0.8606 High Similarity NPD6167 Clinical (unspecified phase)
0.8606 High Similarity NPD6166 Phase 2
0.8405 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8377 Intermediate Similarity NPD2344 Approved
0.8373 Intermediate Similarity NPD6232 Discontinued
0.8354 Intermediate Similarity NPD3749 Approved
0.8344 Intermediate Similarity NPD3817 Phase 2
0.8333 Intermediate Similarity NPD7473 Discontinued
0.8303 Intermediate Similarity NPD919 Approved
0.8294 Intermediate Similarity NPD7074 Phase 3
0.8282 Intermediate Similarity NPD1465 Phase 2
0.8256 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8239 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD5844 Phase 1
0.8235 Intermediate Similarity NPD7054 Approved
0.8224 Intermediate Similarity NPD1240 Approved
0.8224 Intermediate Similarity NPD943 Approved
0.8205 Intermediate Similarity NPD1549 Phase 2
0.8198 Intermediate Similarity NPD6559 Discontinued
0.8187 Intermediate Similarity NPD7472 Approved
0.8165 Intermediate Similarity NPD2309 Approved
0.8141 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8141 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8129 Intermediate Similarity NPD1510 Phase 2
0.8117 Intermediate Similarity NPD1607 Approved
0.8098 Intermediate Similarity NPD4380 Phase 2
0.8063 Intermediate Similarity NPD6799 Approved
0.8038 Intermediate Similarity NPD2800 Approved
0.8035 Intermediate Similarity NPD6797 Phase 2
0.8025 Intermediate Similarity NPD920 Approved
0.8024 Intermediate Similarity NPD7075 Discontinued
0.8024 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD7251 Discontinued
0.7988 Intermediate Similarity NPD6599 Discontinued
0.7962 Intermediate Similarity NPD2796 Approved
0.7952 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD7819 Suspended
0.7943 Intermediate Similarity NPD7808 Phase 3
0.7931 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7925 Intermediate Similarity NPD1243 Approved
0.7914 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7904 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7904 Intermediate Similarity NPD5402 Approved
0.7901 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD6959 Discontinued
0.7862 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7848 Intermediate Similarity NPD2935 Discontinued
0.7831 Intermediate Similarity NPD7411 Suspended
0.7821 Intermediate Similarity NPD230 Phase 1
0.7821 Intermediate Similarity NPD447 Suspended
0.7791 Intermediate Similarity NPD2533 Approved
0.7791 Intermediate Similarity NPD2534 Approved
0.7791 Intermediate Similarity NPD2532 Approved
0.7785 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD6801 Discontinued
0.7778 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD3750 Approved
0.7751 Intermediate Similarity NPD7768 Phase 2
0.7746 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD7199 Phase 2
0.7662 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD1613 Approved
0.7643 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD1551 Phase 2
0.7622 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7588 Intermediate Similarity NPD2296 Approved
0.7586 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD3027 Phase 3
0.7558 Intermediate Similarity NPD6234 Discontinued
0.7557 Intermediate Similarity NPD3751 Discontinued
0.7548 Intermediate Similarity NPD9494 Approved
0.7546 Intermediate Similarity NPD4628 Phase 3
0.7514 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3226 Approved
0.7485 Intermediate Similarity NPD5403 Approved
0.7485 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD8434 Phase 2
0.747 Intermediate Similarity NPD5401 Approved
0.7469 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD2799 Discontinued
0.7453 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD3748 Approved
0.7439 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD4287 Approved
0.7375 Intermediate Similarity NPD1933 Approved
0.7368 Intermediate Similarity NPD37 Approved
0.7362 Intermediate Similarity NPD2346 Discontinued
0.7362 Intermediate Similarity NPD1471 Phase 3
0.7348 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD4965 Approved
0.7341 Intermediate Similarity NPD4967 Phase 2
0.7341 Intermediate Similarity NPD4966 Approved
0.7337 Intermediate Similarity NPD1653 Approved
0.7333 Intermediate Similarity NPD5953 Discontinued
0.733 Intermediate Similarity NPD3787 Discontinued
0.7318 Intermediate Similarity NPD7286 Phase 2
0.7312 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD1203 Approved
0.7305 Intermediate Similarity NPD7390 Discontinued
0.7301 Intermediate Similarity NPD6100 Approved
0.7301 Intermediate Similarity NPD6099 Approved
0.7296 Intermediate Similarity NPD2313 Discontinued
0.7289 Intermediate Similarity NPD6190 Approved
0.7288 Intermediate Similarity NPD5242 Approved
0.7267 Intermediate Similarity NPD6280 Approved
0.7267 Intermediate Similarity NPD6279 Approved
0.7263 Intermediate Similarity NPD7228 Approved
0.7247 Intermediate Similarity NPD2403 Approved
0.7232 Intermediate Similarity NPD5710 Approved
0.7232 Intermediate Similarity NPD7229 Phase 3
0.7232 Intermediate Similarity NPD5711 Approved
0.7226 Intermediate Similarity NPD9269 Phase 2
0.7222 Intermediate Similarity NPD6651 Approved
0.7198 Intermediate Similarity NPD7685 Pre-registration
0.7188 Intermediate Similarity NPD3764 Approved
0.717 Intermediate Similarity NPD4908 Phase 1
0.7167 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD2163 Approved
0.716 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD6808 Phase 2
0.7126 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD8313 Approved
0.712 Intermediate Similarity NPD8312 Approved
0.7115 Intermediate Similarity NPD1608 Approved
0.7115 Intermediate Similarity NPD9717 Approved
0.7101 Intermediate Similarity NPD4357 Discontinued
0.7081 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD2654 Approved
0.7063 Intermediate Similarity NPD6832 Phase 2
0.7051 Intermediate Similarity NPD1610 Phase 2
0.7051 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD6777 Approved
0.7047 Intermediate Similarity NPD6779 Approved
0.7047 Intermediate Similarity NPD6780 Approved
0.7047 Intermediate Similarity NPD6778 Approved
0.7047 Intermediate Similarity NPD6776 Approved
0.7047 Intermediate Similarity NPD6781 Approved
0.7047 Intermediate Similarity NPD6782 Approved
0.7044 Intermediate Similarity NPD2798 Approved
0.7029 Intermediate Similarity NPD5760 Phase 2
0.7029 Intermediate Similarity NPD5761 Phase 2
0.702 Intermediate Similarity NPD8151 Discontinued
0.7018 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD6385 Approved
0.7011 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD6386 Approved
0.7 Intermediate Similarity NPD2861 Phase 2
0.6995 Remote Similarity NPD1729 Discontinued
0.6989 Remote Similarity NPD5353 Approved
0.6981 Remote Similarity NPD1470 Approved
0.6979 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6976 Remote Similarity NPD7907 Approved
0.6975 Remote Similarity NPD411 Approved
0.6975 Remote Similarity NPD3268 Approved
0.6973 Remote Similarity NPD7549 Discontinued
0.6971 Remote Similarity NPD6844 Discontinued
0.6968 Remote Similarity NPD9268 Approved
0.6961 Remote Similarity NPD4111 Phase 1
0.6961 Remote Similarity NPD4665 Approved
0.6957 Remote Similarity NPD1252 Clinical (unspecified phase)
0.6951 Remote Similarity NPD6355 Discontinued
0.695 Remote Similarity NPD7783 Phase 2
0.695 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6948 Remote Similarity NPD5536 Phase 2
0.6943 Remote Similarity NPD422 Phase 1
0.6939 Remote Similarity NPD7435 Discontinued
0.6933 Remote Similarity NPD6233 Phase 2
0.6928 Remote Similarity NPD4308 Phase 3
0.6928 Remote Similarity NPD7033 Discontinued
0.6927 Remote Similarity NPD4362 Clinical (unspecified phase)
0.6927 Remote Similarity NPD4361 Phase 2
0.6923 Remote Similarity NPD17 Approved
0.6915 Remote Similarity NPD8150 Discontinued
0.6914 Remote Similarity NPD4625 Phase 3
0.6904 Remote Similarity NPD7870 Phase 2
0.6904 Remote Similarity NPD7871 Phase 2
0.6903 Remote Similarity NPD1548 Phase 1
0.6899 Remote Similarity NPD3972 Approved
0.6897 Remote Similarity NPD5808 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data